{
    "clinical_study": {
        "@rank": "436",
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on April 14, 2020",
            "link_text": "Link to the current ClinicalTrials.gov record.",
            "url": "https://clinicaltrials.gov/show/NCT04345406"
        },
        "id_info": {
            "org_study_id": "ACEIS COVID 19",
            "nct_id": "NCT04345406"
        },
        "brief_title": "Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19",
        "official_title": "Randomized Trial of ACEIs in Treatment of COVID-19",
        "sponsors": {
            "lead_sponsor": {
                "agency": "Tanta University",
                "agency_class": "Other"
            }
        },
        "source": "Tanta University",
        "oversight_info": {
            "has_dmc": "Yes",
            "is_fda_regulated_drug": "No",
            "is_fda_regulated_device": "No"
        },
        "brief_summary": {
            "textblock": "ACEIs as treatment for COVID19"
        },
        "detailed_description": {
            "textblock": "ACEIs as suggested treatment for COVID19"
        },
        "overall_status": "Not yet recruiting",
        "start_date": {
            "@type": "Anticipated",
            "#text": "April 15, 2020"
        },
        "completion_date": {
            "@type": "Anticipated",
            "#text": "December 1, 2029"
        },
        "primary_completion_date": {
            "@type": "Anticipated",
            "#text": "December 1, 2029"
        },
        "phase": "Phase 3",
        "study_type": "Interventional",
        "has_expanded_access": "No",
        "study_design_info": {
            "allocation": "Randomized",
            "intervention_model": "Parallel Assignment",
            "primary_purpose": "Treatment",
            "masking": "None (Open Label)"
        },
        "primary_outcome": {
            "measure": "number of patients with virological cure",
            "time_frame": "6 months",
            "description": "number of patients with virological cure"
        },
        "number_of_arms": "2",
        "enrollment": {
            "@type": "Anticipated",
            "#text": "60"
        },
        "condition": "COVID",
        "arm_group": [
            {
                "arm_group_label": "ACEIs",
                "arm_group_type": "Experimental",
                "description": "ACEIs with conventional treatment for COVID19"
            },
            {
                "arm_group_label": "Conventional treatment of COVID19",
                "arm_group_type": "Experimental",
                "description": "Conventional treatment of COVID19"
            }
        ],
        "intervention": [
            {
                "intervention_type": "Drug",
                "intervention_name": "ACEIs",
                "description": "Captopril or enalapril",
                "arm_group_label": "ACEIs",
                "other_name": "Enalapril, Captopril"
            },
            {
                "intervention_type": "Drug",
                "intervention_name": "Conventional treatment",
                "description": "alexoquine",
                "arm_group_label": [
                    "ACEIs",
                    "Conventional treatment of COVID19"
                ],
                "other_name": "chloroquine"
            }
        ],
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients infected with covid 19\n\n        Exclusion Criteria:\n\n          -  allergy or contraindications to the drug"
            },
            "gender": "All",
            "minimum_age": "N/A",
            "maximum_age": "N/A",
            "healthy_volunteers": "No"
        },
        "overall_official": {
            "last_name": "Sherief Abd-Elsalam, ass. prof.",
            "role": "Principal Investigator",
            "affiliation": "Tanta University Faculty of medicine"
        },
        "overall_contact": {
            "last_name": "Sherief Abd-Elsalam",
            "phone": "+201147773440",
            "email": "sheriefabdelsalam@yahoo.com"
        },
        "location": {
            "facility": {
                "name": "Tanta University",
                "address": {
                    "city": "Tanta",
                    "zip": "35111",
                    "country": "Egypt"
                }
            }
        },
        "location_countries": {
            "country": "Egypt"
        },
        "verification_date": "April 2020",
        "study_first_submitted": "April 11, 2020",
        "study_first_submitted_qc": "April 11, 2020",
        "study_first_posted": {
            "@type": "Estimate",
            "#text": "April 14, 2020"
        },
        "last_update_submitted": "April 11, 2020",
        "last_update_submitted_qc": "April 11, 2020",
        "last_update_posted": {
            "@type": "Estimate",
            "#text": "April 14, 2020"
        },
        "responsible_party": {
            "responsible_party_type": "Principal Investigator",
            "investigator_affiliation": "Tanta University",
            "investigator_full_name": "Sherief Abd-Elsalam",
            "investigator_title": "assistant professor of tropical medicine and infectious diseases"
        },
        "intervention_browse": {
            "mesh_term": [
                "Enalapril",
                "Captopril"
            ]
        },
        "patient_data": {
            "sharing_ipd": "No"
        }
    }
}